Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2013-08-16 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
拟收购张泽军先生实际控制的上海明伦医疗器材有限公司等五家公司股权评估项目评估报告
Capital/Financing Update Classification · 95% confidence The document is a detailed asset valuation report for a proposed acquisition by 嘉事堂药业股份有限公司 of shares in 上海明伦医疗器材有限公司 and four other companies. It includes an asset appraiser's statement, valuation methods (asset-based and income-based), financial data of the target companies, shareholder information, and the valuation conclusion as of June 30, 2013. The document is not an announcement or a brief summary but a full valuation report with extensive financial and operational details. It is not an annual report, earnings release, or management report but a specialized valuation report related to a capital transaction. This fits the category of a Capital/Financing Update (CAP), as it relates to a financing activity (acquisition) and provides valuation information to support that transaction.
2013-08-16 Chinese
拟收购谢东华先生、李燕女士实际控制的武汉恺通科技发展有限公司等三家公司股权项目评估说明
Audit Report / Information Classification · 95% confidence The document is a detailed asset valuation report related to the acquisition of equity in three companies controlled by specific individuals. It includes extensive financial data, asset and liability evaluations, audit references, and valuation methodologies such as the asset-based approach and discounted cash flow (DCF) method. The document is not a brief announcement but a comprehensive assessment with financial figures and analysis. It is not an annual or quarterly report, nor a regulatory filing or announcement. It is a standalone audit and valuation report prepared for acquisition purposes, fitting the category of Audit Report / Information (AR). H1 2013
2013-08-16 Chinese
第四届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the eighth meeting of the fourth board of directors of 嘉事堂药业股份有限公司. It includes details about appointments of senior management positions (vice presidents and assistant to the president), approval of acquisition proposals, amendments to company bylaws, and the calling of an extraordinary shareholders meeting. The document also provides biographies of the newly appointed senior executives. There are no financial statements or detailed financial data presented. The content focuses on board decisions and management changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 3368 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report or financial disclosure.
2013-08-16 Chinese
关于收购自然人张泽军先生所拥有并实际控制的上海明伦医疗器械有限公司等五家单位部分股权并增资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the acquisition of equity interests in several companies by 嘉事堂药业股份有限公司. It details the transaction overview, parties involved, financial data of the target companies, payment terms, shareholding changes, and the impact and risks of the acquisition. It includes board meeting resolutions approving the transaction and mentions related audit and valuation reports. The content focuses on a capital acquisition transaction and financing details rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to the clear focus on acquisition and capital structure changes.
2013-08-16 Chinese
第四届监事会第六次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (575 characters) regarding the resolution of the Supervisory Board meeting approving the 2013 semi-annual report. It states that the Supervisory Board reviewed and approved the half-year report and confirms its accuracy and compliance. The document does not contain the actual financial statements or detailed financial data but is an announcement of the approval of the interim report. According to the 'Menu vs Meal' rule, such a short document announcing the approval of a report without including the report itself should be classified as a Regulatory Filing (RNS).
2013-07-17 Chinese
第四届董事会第七次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the seventh meeting of the fourth board of directors of 嘉事堂药业股份有限公司. It specifically mentions the approval of the '2013 半年度报告' (2013 Semi-Annual Report) by the board. The document is short (541 characters) and serves as a formal notice of the board meeting decisions rather than the report itself. Therefore, it is not the interim/quarterly report (IR) but an announcement related to board/management information, specifically about board meeting resolutions. This fits the category of Board/Management Information (MANG).
2013-07-17 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.